I think this is a fair refutation of your "honest

New Post Public Reply Private Reply Replies (0) Message Board
B.Izzy lousy.engineer #48082
312
I think this is a fair refutation of your "honest brokering' of realistic views....lifted in toto from a fellow long

IPIX vs Galera were for the same indication, oral mucositis, but other than that apples and oranges IMO.

IPIX is for a drug administered via swish and spit
Galera is an intravenous injection an hour or more a day for 3 to 5 weeks.

IPIX showed no side effects
Galera showed some very definite side effects that were allowed as they ran their test as a cancer drug which allows more severe reactions than a non-cancer test (at least this is what I understand).

As to the timing, I believe the main time delay is due to IPIX bringing B-OM into a delivery form using sachets, which totally destroys Galera in terms of patient administering the drug to themselves. doctors being much more willing to use it, and insurance companies to pay for it. Cost should also be a major advantage for IPIX as it costs much to get hospital attention daily for weeks on end.

I think it best to allow Galera to do their thing and make their product as attractive as possible, allow IPIX to do the same, and see what the patients think about what therapy they want to follow.

Pat on the back to Galera, but not willing to admonish IPIX as we are working on a different approach and it takes longer as evidenced by us having to sign contracts with both Evonik and CoreRx.

Another area we are just going to have to respectfully disagree.

Edit: I also believe there is a very good chance we get some sort of partnership for B-OM by end of Sept. Not sure the form it will take but some type of deal (mainly expecting a worldwide partner except for USA)

Edit Edit: Why get BTD before sachets are available as we would not be able to ship any product to those requesting it? That is why I believe the BTD wasn't requested until after CoreRx contract was finalized.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sony's LYTIA 720 Image Sensor: A Game Changer?

Updated Category News Views 58

Unpacking Sony's Latest Sensor: LYTIA 720 Tell me, when was the last time a tech drop made you shake your head in awe? Sony just pulled one of those moves with their latest toy, the LYTIA 720. We're talking a 50-effective megapixel CMOS image sensor crafted for mobile warriors, and it packs a punch that should have the competition looking over their shoulder. Dazzling...

Continue Reading
Infoya Surges with 665% Growth, Wins Fast 50 Spot

Updated Category News Views 43

From Humble Beginnings to High Achiever Alright, let's touch base on Canada's tech landscape for a moment. Infoya's leap into Deloitte's 2026 Technology Fast 50 isn't just a pat on the back—it's a flashing neon sign of what raw ambition mixed with a pinch of AI can cook up for you. They've banked a whopping 665% revenue growth from 2022 to 2025. Not bad for a company...

Continue Reading
Federal Signal Acquires GVS, Boosts Vacuum Truck Lineup

Updated Category News Views 17

Federal Signal's Latest Move in Vacuum Truck Arena A shakeup in the vacuum truck market? You bet. Federal Signal Corporation has made waves yet again by acquiring the lion's share of Global Vacuum Systems (GVS) assets and operations. We're talking a transaction valued at a hefty $29 million. Dishing Out the Dollars and Cents Now, what stirs the pot in this deal is the...

Continue Reading
Beta Bionics Faces Securities Fraud Class Action Challenges

Updated Category News Views 39

The Unexpected Slide of Beta Bionics So your wallet took a bruising with this Beta Bionics deal, eh? It’s another one of those wild tales from the stock jungle where everyone watching the NASDAQ:BBNX action got clipped when reality didn't match the company chest-thumping. Glancy Prongay Wolke & Rotter LLP just laid it out—ripping the Band-Aid off what Beta Bionics...

Continue Reading
2026 Data Integration Stars: User Sentiments Revealed

Updated Category News Views 0

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Continue Reading
Biopharma Rethinks Strategy Amid U.S. MFN Pricing Shift

Updated Category News Views 83

Global Pharma Grapples with U.S. MFN Pricing Sometimes, regulatory changes hit the industry like a freight train, and other times they creep in like the tide reshaping everything without much fanfare. The U.S. Most-Favored-Nation (MFN) pricing rule, spotlighted in a recent World ACCESS Consortium (WAC) white paper, might be the latter. It’s bending biopharmaceuticals'...

Continue Reading
Ecopetrol Sets Q3 2026 Results Release, Conference Call

Updated Category News Views 110

Big Day Incoming: Ecopetrol's Q3 Results Alright, folks, buckle up because Ecopetrol is about to drop its third-quarter numbers for 2026. On November 10th, after the bell, Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) will lift the veil on its financial and operational performance. Make sure you got your calendars marked, and better yet, your browser's up to date. Nothing's...

Continue Reading
Smartpress: Adobe & Canva Shape Print Design World

Updated Category News Views 54

Adobe's Stranglehold on Professional Design Over at Smartpress, they've pulled the curtain back on just how heavily Adobe Creative Suite weighs in on the print design sector. The company's recent analysis shines a light on the staggering 66% dominance of Adobe's InDesign and Illustrator in file submissions. That's a hefty portion influencing both the quality and financial...

Continue Reading
First Responders Honored in Times Square Hero Ceremony

Updated Category News Views 56

Stepping up to Spotlight Courage In a world that often seems to teeter on chaos, it's those unsung heroes—the first responders—who stand ready to turn panic into repose. October 28th saw Times Square in New York City transform into a beacon of appreciation as the First Responders Children's Foundation (FRCF) applauded nineteen fearless foes of danger. Picture that...

Continue Reading
Uwharrie Capital's 2026 Q3 Shows Steady Growth

Updated Category News Views 11

Uwharrie Capital's Financial Dance Well, don't dust off the neon ticker tape quite yet but Uwharrie Capital Corp (OTCQX:UWHR) gave us a reason to nod approvingly over our espresso this quarter. From a scrappy hometown operation to a regional bank showing its mettle, the numbers they've laid down ain't half bad. Assets Climb a Billion-Dollar Ladder First thing that jumps...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Push Charles Schwab Options Amid Market Speculations

Updated Category News Views 231

Investors Show Caution with Charles Schwab Options Amid Market Speculations Investors seem to be taking a measured approach when it comes to Charles Schwab (NYSE: SCHW). They've been actively engaged in options trading, which isn't going unnoticed. Recent analysis suggests that some of the big players in finance are leaning towards a more bearish outlook, hinting at...

Continue Reading
Premier Truck Rental Introduces Compact Crane Add-On Option

Updated Category News Views 70

Introducing Premier Truck Rental's New Crane Add-On Premier Truck Rental (PTR) is excited to unveil its latest enhancement to its upfit offerings: a compact crane add-on. This innovative solution features a 4-foot crane with a maximum load capacity of 900 pounds, designed to address a variety of lifting needs across different applications. Fleet managers now have the...

Continue Reading
Jim Cramer's Investment Insights: Focus on Lam Research and More

Updated Category News Views 65

Investing Insights from Jim Cramer In a recent episode of CNBC's “Mad Money Lightning Round,” investment expert Jim Cramer highlighted a few key stocks to watch in the current market landscape. His notable recommendation was for investors to consider Lam Research Corporation (NASDAQ: LRCX), expressing his strong approval. Cramer stated, “I like it very much here,”...

Continue Reading
Revolutionizing Case Preparation with AAAi Chat Book Launch

Updated Category News Views 103

Introduction to AAAi Chat Book The American Arbitration Association (AAA) and its international division, the International Centre for Dispute Resolution (ICDR), have introduced an innovative tool aimed at transforming the way cases are prepared and presented. The launch of the AAAi Chat Book Case Preparation and Presentation marks a significant milestone in the field of...

Continue Reading
Richtech Robotics’ AI Robot ADAM Showcases Innovation at VIP Gala

Updated Category News Views 109

Richtech Robotics’ ADAM Robot to Shine at Exclusive Event Richtech Robotics Inc. (Nasdaq: RR) has announced that its advanced robot, ADAM, is set to make a captivating appearance at a prestigious event focused on space exploration. This invitation-only affair will showcase the robot's unique ability to serve space-themed cocktails, adding a fun twist to the gathering....

Continue Reading